Can you answer the fol­low­ing ques­tion correctly?

In 2011, a work­group con­sist­ing of Amer­i­can Soci­ety of Clin­i­cal Oncol­ogy (ASCO) and ONS mem­bers was con­vened to review feed­back received since pub­li­ca­tion of the ASCO/​​ONS Stan­dards for Safe Chemother­apy Admin­is­tra­tion in 2009 and to clar­ify the stan­dards as needed. The most sig­nif­i­cant change is the deci­sion to extend their scope to the inpa­tient set­ting. This